Structural basis for inhibition of the fat mass and obesity associated protein (FTO).
The fat mass and obesity associated protein (FTO) is a potential target for anti-obesity medicines. FTO is a 2-oxoglutarate (2OG)-dependent N-methyl nucleic acid demethylase that acts on substrates including 3-methylthymidine, 3-methyluracil, and 6-methyladenine. To identify FTO inhibitors, we scree...
Main Authors: | Aik, W, Demetriades, M, Hamdan, M, Bagg, E, Yeoh, K, Lejeune, C, Zhang, Z, McDonough, M, Schofield, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Structure-based design of selective fat mass and obesity associated protein (FTO) inhibitors
by: Shishodia, S, et al.
Published: (2021) -
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
by: Church, C, et al.
Published: (2009) -
A dominant mutation in the obesity susceptibility gene FTO results in reduced fat mass with enhanced lipid and carbohydrate metabolism
by: Church, C, et al.
Published: (2009) -
A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene.
by: Chris Church, et al.
Published: (2009-08-01) -
Investigating the role of the fat mass and obesity associated gene (Fto) in obesity
by: McMurray, F
Published: (2013)